The Role of Disulfide Bonds in Structure and Activity of Chlorotoxin

References

• Debin JA , MaggioJE, StrichartzGR. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am. J. Physiol.264 (2 Pt 1), C361–C369 (1993).
   PubMedGoogle Scholar
• Lyons SA , O'NealJ, SontheimerH. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin. Glia39 (2), 162–173 (2002).
   PubMed Web of Science ®Google Scholar
• Jacoby DB , DyskinE, YalcinMet al. Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide. Anticancer Res.30 (1), 39–46 (2010).
   PubMed Web of Science ®Google Scholar
• Soroceanu L , GillespieY, KhazaeliMB, SontheimerH. Use of chlorotoxin for targeting of primary brain tumors. Cancer Res.58 (21), 4871–4879 (1998).
   PubMed Web of Science ®Google Scholar
• Ullrich N , GillespieGY, SontheimerH. Human astrocytoma cells express a unique chloride current. Neuroreport7 (5), 1020–1024 (1996).
   PubMed Web of Science ®Google Scholar
• Deshane J , GarnerCC, SontheimerH. Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J. Biol. Chem.278 (6), 4135–4144 (2003).
   PubMed Web of Science ®Google Scholar
• Kesavan K , RatliffJ, JohnsonEWet al. Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects. J. Biol. Chem.285 (7), 4366–4374 (2010).
   PubMed Web of Science ®Google Scholar
• Stroud MR , HansenSJ, OlsonJM. In vivo bio-imaging using chlorotoxin-based conjugates. Curr. Pharm. Des.17 (38), 4362–4371 (2011).
   PubMed Web of Science ®Google Scholar
• Veiseh M , GabikianP, BahramiSBet al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res.67 (14), 6882–6888 (2007).
   PubMed Web of Science ®Google Scholar
• Kovar JL , CurtisE, OthmanSF, SimpsonMA, OliveDM. Characterization of IRDye 800CW chlorotoxin as a targeting agent for brain tumors. Anal. Biochem.440 (2), 212–219 (2013).
   PubMed Web of Science ®Google Scholar
• Hockaday DC , ShenS, FiveashJet al. Imaging glioma extent with 131I-TM-601. J. Nucl. Med.46 (4), 580–586 (2005).
   PubMed Web of Science ®Google Scholar
• Mamelak AN , RosenfeldS, BucholzRet al. Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma. J. Clin. Oncol.24 (22), 3644–3650 (2006).
   PubMed Web of Science ®Google Scholar
• Costa PM , CardosoAL, MendoncaLSet al. Tumor-targeted chlorotoxin-coupled nanoparticles for nucleic acid delivery to glioblastoma cells: a promising system for glioblastoma treatment. Mol. Ther. Nucleic Acids2, e100 (2013).
   PubMedGoogle Scholar
• Graf N , MokhtariTE, PapayannopoulosIA, LippardSJ. Platinum(IV)-chlorotoxin (CTX) conjugates for targeting cancer cells. J. Inorg. Biochem.110, 58–63 (2012).
   PubMed Web of Science ®Google Scholar
• Akcan M , StroudMR, HansenSJet al. Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J. Med. Chem.54 (3), 782–787 (2011).
   PubMed Web of Science ®Google Scholar
• Lippens G , NajibJ, WodakSJ, TartarA. NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels. Biochemistry34 (1), 13–21 (1995).
   PubMed Web of Science ®Google Scholar
• Daly NL , CraikDJ. Bioactive cystine knot proteins. Curr. Opin. Chem. Biol.15 (3), 362–368 (2011).
   PubMed Web of Science ®Google Scholar
• Garcia AE , CamareroJA. Biological activities of natural and engineered cyclotides, a novel molecular scaffold for peptide-based therapeutics. Curr. Mol. Pharmacol.3 (3), 153–163 (2010).
   PubMedGoogle Scholar
• Wong CT , RowlandsDK, WongCHet al. Orally active peptidic bradykinin B1 receptor antagonists engineered from a cyclotide scaffold for inflammatory pain treatment. Angew. Chem. Int. Ed. Engl.51 (23), 5620–5624 (2012).
   PubMed Web of Science ®Google Scholar
• Gongora-Benitez M , Tulla-PucheJ, AlbericioF. Multifaceted roles of disulfide bonds. Peptides as therapeutics. Chem. Rev.114 (2), 901–926 (2014).
   PubMed Web of Science ®Google Scholar
• Colgrave ML , CraikDJ. Thermal, chemical and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry43 (20), 5965–5975 (2004).
   PubMed Web of Science ®Google Scholar
• Wang CK , HuSH, MartinJLet al. Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold. J. Biol. Chem.284 (16), 10672–10683 (2009).
   PubMed Web of Science ®Google Scholar
• Chan LY , ZhangVM, HuangYHet al. Cyclization of the antimicrobial peptide gomesin with native chemical ligation: influences on stability and bioactivity. Chembiochem14 (5), 617–624 (2013).
   PubMed Web of Science ®Google Scholar
• Zhu Q , LiangS, MartinL, GaspariniS, MenezA, VitaC. Role of disulfide bonds in folding and activity of leiurotoxin I: just two disulfides suffice. Biochemistry41 (38), 11488–11494 (2002).
   PubMed Web of Science ®Google Scholar
• Drakopoulou E , VizzavonaJ, NeytonJet al. Consequence of the removal of evolutionary conserved disulfide bridges on the structure and function of charybdotoxin and evidence that particular cysteine spacings govern specific disulfide bond formation. Biochemistry37 (5), 1292–1301 (1998).
   PubMed Web of Science ®Google Scholar
• Colgrave ML , PothAG, KaasQ, CraikDJ. A new “era” for cyclotide sequencing. Biopolymers94 (5), 592–601 (2010).
   PubMed Web of Science ®Google Scholar
• Chan LY , GunasekeraS, HenriquesSTet al. Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood118 (25), 6709–6717 (2011).
   PubMed Web of Science ®Google Scholar
• Conibear AC , RosengrenKJ, DalyNL, HenriquesST, CraikDJ. The cyclic cystine ladder in theta-defensins is important for structure and stability, but not antibacterial activity. J. Biol. Chem.288 (15), 10830–10840 (2013).
   PubMed Web of Science ®Google Scholar
• Aboye TL , ClarkRJ, BurmanR, RoigMB, CraikDJ, GoranssonU. Interlocking disulfides in circular proteins: toward efficient oxidative folding of cyclotides. Antioxid. Redox Signal.14 (1), 77–86 (2011).
   PubMed Web of Science ®Google Scholar
• Greenfield NJ . Using circular dichroism spectra to estimate protein secondary structure. Nat. Protoc.1 (6), 2876–2890 (2006).
   PubMed Web of Science ®Google Scholar
• Sabatier JM , LecomteC, MabroukKet al. Synthesis and characterization of leiurotoxin I analogs lacking one disulfide bridge: evidence that disulfide pairing 3–21 is not required for full toxin activity. Biochemistry35 (33), 10641–10647 (1996).
   PubMed Web of Science ®Google Scholar
• Vlieghe P , LisowskiV, MartinezJ, KhrestchatiskyM. Synthetic therapeutic peptides: science and market. Drug Discov. Today15 (1–2), 40–56 (2010).
   PubMed Web of Science ®Google Scholar
• Clark RJ , FischerH, DempsterLet al. Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MII. Proc. Natl Acad. Sci. USA102 (39), 13767–13772 (2005).
   PubMed Web of Science ®Google Scholar
• Clark RJ , JensenJ, NevinST, CallaghanBP, AdamsDJ, CraikDJ. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew. Chem. Int. Ed. Engl.49 (37), 6545–6548 (2010).
   PubMed Web of Science ®Google Scholar
• Jia X , KwonS, WangCIet al. Semienzymatic cyclization of disulfide-rich peptides using Sortase A. J. Biol. Chem.289 (10), 6627–6638 (2014).
   PubMed Web of Science ®Google Scholar
• Borra R , CamareroJA. Recombinant expression of backbone-cyclized polypeptides. Biopolymers100 (5), 502–509 (2013).
   PubMed Web of Science ®Google Scholar
• Halai R , CallaghanB, DalyNL, ClarkRJ, AdamsDJ, CraikDJ. Effects of cyclization on stability, structure and activity of alpha-conotoxin RgIA at the alph9alpha10 nicotinic acetylcholine receptor and GABA(B) receptor. J. Med. Chem.54 (19), 6984–6992 (2011).
   PubMed Web of Science ®Google Scholar
• Lovelace ES , GunasekeraS, AlvarmoCet al. Stabilization of alpha-conotoxin AuIB: influences of disulfide connectivity and backbone cyclization. Antioxid. Redox Signal.14 (1), 87–95 (2011).
   PubMed Web of Science ®Google Scholar
• Wang CK , GruberCW, CemazarMet al. Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis. ACS. Chem. Biol.9 (1), 156–163 (2014).
   PubMed Web of Science ®Google Scholar
• Ji Y , MajumderS, MillardMet al. In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. J. Am. Chem. Soc.135 (31), 11623–11633 (2013).
   PubMed Web of Science ®Google Scholar